A Comparative Evaluation of Different Histopathological Indices of Mucosal Healing in Ulcerative Colitis
Observational · No treatment assigned · Sites not listed yet · Assiut University
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
Condition(s) listed: Ulcerative Colitis. This is an observational study: researchers collect information (for example questionnaires, samples, or scans) but the study does not assign a treatment.
Who can join
- Ages 18 to 80
- Any sex
Some of the main requirements, copied from the record:
- Adult patients >18 years diagnosed with ulcerative colitis based on standard clinical, endoscopic, and histological criteria
There are also 1 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 60 participants are expected to take part.
- Start date: 2025-06 (planned).
- Main results expected around 2026-09 (estimate from the record).
- No study sites are listed yet. Check the official record for contact details.
Main thing being measured
- A Comparative Evaluation of Different Histopathological Indices of Mucosal Healing in Ulcerative Colitis, and their Correlation with Clinical Follow-up Data (4 months)
In the researchers’ words
* To evaluate the histological activity and the presence of specific histopathologic features at diagnosis in ulcerative colitis patients before and after receiving treatment using the three most widely- used histological scoring indices (Gobeos score , Robarts Histopathologic Index and Nancy Index ) * To compare the findings of the three histopathological indices with each other as a trial to select the best,…
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Not yet recruiting |
|---|---|
| Phase | Observational |
| Study type | Observational |
| Conditions | Ulcerative Colitis |
| Lead sponsor | Assiut University |
| Enrollment | 60 (estimated) |
| Start date | 2025-06 |
| Primary completion (est.) | 2026-09 |
| First posted | 2025-04-09 |
| Last updated | 2025-04-13 |
| Official title | A Comparative Evaluation of Different Histopathological Indices of Mucosal Healing in Ulcerative Colitis, and Their Correlation With Clinical Follow-up Data |
| ClinicalTrials.gov ID | NCT06918093 |
Interventions
- None listed
Full eligibility criteria (from the record)
Inclusion Criteria: * Adult patients >18 years diagnosed with ulcerative colitis based on standard clinical, endoscopic, and histological criteria Exclusion Criteria: * Patients lost to follow-up and those with insufficient data
Locations (0)
No sites listed yet. The official record has contact information.
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.